• A review of international and Russian scientific data on the use of Polyninax for the treatment and prevention of nonspecific (aerobic), candidal and mixed vaginitis

A review of international and Russian scientific data on the use of Polyninax for the treatment and prevention of nonspecific (aerobic), candidal and mixed vaginitis

HEALTH OF WOMAN. 2018.3(129):58–69

Kira E. F., Savicheva A. M.
IV for the NMTS N.I. Pirogov, Ministry of Healthcare and Social Development, Moscow, Russia
FSBU Scientific Research Institute of Obstetrics and Gynecology D.O. Otta, Moscow, Russia

RUSSIAN BULLETIN OF OBJECTIVE-GYNECOLOGIST 1, 2018

REFERENCES

1. Rukovodstvo po ambulatorno-poliklinicheskoy pomoschi v akusherstve i ginekologii. Pod red. VE Radzinskogo. 2-e izd., pererab. i dop. M, GEOTAR-Media. 2014:944.

2. Esim BЕ, Kars B, Karsidag AY, Karadeniz BI et al. 2010. Diagnosis of vulvovaginitis: comparison of clinical and microbiological diagnosis. Arch Gynecol Obstet 282(5):515–519. https://doi.org/10.1007/s00404-010-1498-x; PMid:20461391

3. Mylonas I, Bergauer F. 2011, Jun. Diagnosis of vaginal discharge by wet mount microscopy: a simple and underrated method. Obstet Gynecol Surv. 66(6):359–68. https://doi.org/10.1097/OGX.0b013e31822bdf31; PMid:21851750

4. Gajer P, Brotman RM, Bai G et al. 2012, May 2. Temporal dynamics of the human vaginal microbiota. Sci Trans Med 4(132):132ra52. https://doi.org/10.1126/scitranslmed.3003605; PMid:22553250 PMCid:PMC3722878

5. Huang B, Fettweis JM, Brooks JP et al. 2014. The changing landscape of the vaginal microbiome. Clin Lab Med. 34:747-61. https://doi.org/10.1016/j.cll.2014.08.006; PMid:25439274 PMCid:PMC4254509

6. Jasarevic E, Howerton CL, Howard CD, Bale TL. 2015. Alterations in the vaginal microbiome by maternal stress are associated with metabolic reprogramming of the offspring gut and brain. Endocrinology 156:3265-76. https://doi.org/10.1210/en.2015-1177; PMid:26079804 PMCid:PMC4541625

7. Oh HY, Seo SS, Kong JS et al. 2015. Association between obesity and cervical microflora dominated by Lactobacillus iners in Korean women. J Clin Microbiol 53:3304-9. https://doi.org/10.1128/JCM.01387-15; PMid:26269625 PMCid:PMC4572524

8. Brotman RM, He X, Gajer P et al. 2014. Association between cigarette smoking and the vaginal microbiota: a pilot study. BMC Infect Dis 14:471. https://doi.org/10.1186/1471-2334-14-471; PMid:25169082 PMCid:PMC4161850

9. Hay P, Donders G, Giraldo P, Lepargneur JP. 2017. Key Opinions in Medicine. New Perspectives in the Diagnosis and Treatment of Vaginal Infections. Obstet Gynecol 2(1). http:// keyopinions.info/downloads/new-perspectives-diagnosis- treatment-vaginal-infections/

10. Olina AA. 2009. Nespetsificheskie infektsionnyie zabolevaniya vlagalischa (mediko-sotsialnyie, etiologicheskie, kliniko-diagnosticheskie osobennosti). Avtoref. dis. kand. med. nauk. Perm:24.

11. Donders GG, Vereecken A, Bosmans E et al. 2002. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 109:34–43. https://doi.org/10.1111/j.1471-0528.2002.00432.x; PMid:11845812

12. Kenyon C, Colebunders R, Crucitti T. 2013. The global epidemiology of bacterial vaginosis: a systematic review. Am J Obstet Gynecol 209(6):505–23. https://doi.org/10.1016/j.ajog.2013.05.006; PMid:23659989

13. Zozaya-Hinchliffe M, Lillis R, Martin DH, Ferris MJ. 2010. Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol 48(5):1812–9. https://doi.org/10.1128/JCM.00851-09; PMid:20305015 PMCid:PMC2863870

14. Donders GG, Ruban K, Bellen G. 2015, May. Selecting anti-microbial treatment of aerobic vaginitis. Curr Infect Dis Rep. 17(5):47. https://doi.org/10.1007/s11908-015-0477-6; PMid:25896749

15. Liang Q, Li N, Song S et al. 2016, Oct. High-dose nifuratel for simple and mixed aerobic vaginitis: A single-center prospective open-label cohort study. J Obstet Gynecol Res. 42(10):1354–1360. https://doi.org/10.1111/jog.13052; PMid:27435791

16. CDC. MMWR Vulvovaginal candidiasis Sexually transmitted diseases treatment guidelines. 2010. 59:61–3.

17. Sobel JD. 2007. Vulvovaginal candidiasis. Lancet 369:1961–717. https://doi.org/10.1016/S0140-6736(07)60917-9

18. Paulitsch A, Weger W, Ginter-Hanselmayer G et al. 2006. A 5-year (2000–2004) epidemiological survey of Candida and non-Candida yeast species causing vulvovaginal candidiasis in Graz, Austria. Mycoses 49:471–5. https://doi.org/10.1111/j.1439-0507.2006.01284.x; PMid:17022763

19. Donders GG, Bosmans E, Dekeersmaecker A, Vereecken A et al. 2000. Pathogenesis of abnormal vaginal bacterial flora. Am J Obstet Gynecol 182(4):872–878. https://doi.org/10.1016/S0002-9378(00)70338-3

20. Sobel JD, Subramanian C, Foxman B et al. 2013. Mixed vaginitis-more than coinfection and with therapeutic implications. Curr Infect Dis Rep 15(2):104-108. https://doi.org/10.1007/s11908-013-0325-5; PMid:23354954

21. Bohbot J-M, Sednaoui P, Verriere F. 2014. Nystatin-Neomycin-Polymyxin B. Combination: Efficacy and Tolerance as 1st-Line Local Treatment of Infectious Vaginitis. Open J Obstet Gynecol 4:445–454. https://doi.org/10.4236/ojog.2014.47065

22. Landers DV, Wiesenfeld HC, Heine RP et al. 2004. Predictive Value of the Clinical Diagnosis of Lower Genital Tract Infection in Women. Am J Obstet Gynecol 190:1004–1008. https://doi.org/10.1016/j.ajog.2004.02.015; PMid:15118630

23. Radzinskiy VE, Ordiyants IM, Pobedinskaya OS, Buyanova NV. 2013. Sovremennyie aspektyi korrektsii disbioticheskih narusheniy v ginekologicheskoy praktike. Akush. i gin. 2:72–76.

24. Radzinskiy VE, Ordiyants IM, Pobedinskaya OS, Zyikov EV. 2016. Opyit primeneniya preparata Polizhinaks v lechenii vulvovaginitov, vyizvannyih aerobnoy i smeshannoy mikrofloroy. Rossiyskiy vestnik akushera-ginekologa 1:45–48.

25. Sravnitelnaya otsenka aktivnosti sostavlyayuschih preparatov Polizhinaks i Terzhinan in vitro. Meditsinskie aspektyi zdorovya zhenschinyi. Spetsialnyiy vyipusk. Infektsii v akusherstve i ginekologii. 2012:22–24.

26. Boisnik S, Branchet MS. 2012. Otsenka protivovospalitelnogo effekta preparata Polizhinaks. Meditsinskie aspektyi zdorovya zhenschinyi 4(56):22–28.

27. Savicheva AM, Ryibina EV. 2012. Otsenka deystviya Polizhinaksa na mikroorganizmyi, vyidelennyie iz vlagalischa zhenschin, v opyite in vitro. Rossiyskiy vestnik akushera-ginekologa 4:104–107.

28. Nolewajka-Lasak I, Rajca М, KamiAski K et al. 2003. Antibiotic sensitivity of Enterobacteriaceae isolated from women vagina and uterine cervix. Med Dosw Mikrobiol 55(4):351–356.

29. Paterson DL. 2006. Resistance in gram-negative bacteria: enterobacteriaceae. Am J Med 119:6(Suppl 1):20–28.

30. Vermitsky JP, Self MJ, Chadwick SG et al. 2008. Survey of vaginal­flora Candida species isolates from women of different age groups by use of species-specific PCR detection. J Clin Microbiol 46:1501–3. https://doi.org/10.1128/JCM.02485-07; PMid:18305136 PMCid:PMC2292962

31. Richter SS, Galask RP, Messer SA et al. 2005. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol 43:2155–62. https://doi.org/10.1128/JCM.43.5.2155-2162.2005; PMid:15872235 PMCid:PMC1153777

32. Donders GG, Bellen G, Mendling W. 2010. Management of recurrent vulvovaginal candidosis as a chronic illness. Gynecol Obstet Invest 70:306–21. https://doi.org/10.1159/000314022; PMid:21051852

33. Sherrard J, Donders G, White D, Jensen JS. 2011. European IUSTI. European (IUSTI/WHO) guideline on the management of vaginal discharge, 2011. J STD AIDS 22:4211–9.

34. Choukri F, Benderdouche M, Sednaoui P. 2014. In vitro susceptibility profile of 200 recent clinical isolates of Candida spp. to topical antifungal treatments of vulvovaginal candidiasis, the imidazoles and nystatin agents. J Mycol Med 24:303–307. https://doi.org/10.1016/j.mycmed.2014.05.001; PMid:25442913

35. Achkar JM, Fries BC. 2010. Candida infections of the genitourinary tract. Clin Microbiol Rev 23:253–73. https://doi.org/10.1128/CMR.00076-09; PMid:20375352 PMCid:PMC2863365

36. Neut C, Verrière F, Nelis HJ, Coenye T. 2015. Topical Treatment of Infectious Vaginitis: Effects of Antibiotic, Antifungal and Antiseptic Drugs on the Growth of Normal Vaginal Lactobacillus Strains. Open J Obstet Gynecol 5:173–180. https://doi.org/10.4236/ojog.2015.53024

37. Serov VN. 2001. Lechenie nespetsificheskih bakterialnyih i gribkovyih kolpitov Polizhinaksom. Vestnik rossiyskoy assotsiatsii akusherov-ginekologov 1:64–67.

38. Kira EF, Artyimuk NV, Gaytukieva RA, Muslimova SZ. 2010. Biotsenoz i funktsionalnaya aktivnost epiteliya vlagalischa pri mestnom lechenii aerobnogo vaginita polizhinaksom i terzhinanom. Zhurnal akusherstva i zhenskih bolezney LIX(5):127–135.

39. Ozolinya LA, Lapina IA, Bondarenko KR. 2016. Profilaktika infektsionnyih oslozhneniy malyih ginekologicheskih operatsiy. Voprosyi ginekologii, akusherstva i perinatologii 15(1):16–20.